Advanced Search
Search
  
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Other News Releases in Health Care & Hospitals

Washington Lupus Chapter Celebrates 35th Anniversary on December 5

HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008

'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals

 

Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5

SEATTLE, Nov. 2 /PRNewswire-FirstCall/ -- On Thursday, November 5, 2009, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2009 third quarter financial results.

    Conference Call Numbers
    Thursday, November 5
    8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time
    1-877-941-6010 (US Participants)
    1-1-480-629-9772 (International)

    Call-back numbers for post-call listening available at 10:30 a.m. Eastern:
    1-800-406-7325 (US Participants)
    1-303-590-3030 (International)
    Passcode: 4168724#

    Live audio webcast at www.celltherapeutics.com will be archived for
    post-call listening approximately two hours after the call ends.

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: deramian@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.